[go: up one dir, main page]

BRPI0813391A2 - Nutrição pra lactente e criança na primeira infância, e, uso da mesma. - Google Patents

Nutrição pra lactente e criança na primeira infância, e, uso da mesma.

Info

Publication number
BRPI0813391A2
BRPI0813391A2 BRPI0813391-3A2A BRPI0813391A BRPI0813391A2 BR PI0813391 A2 BRPI0813391 A2 BR PI0813391A2 BR PI0813391 A BRPI0813391 A BR PI0813391A BR PI0813391 A2 BRPI0813391 A2 BR PI0813391A2
Authority
BR
Brazil
Prior art keywords
infant
nutrition
child
same
early childhood
Prior art date
Application number
BRPI0813391-3A2A
Other languages
English (en)
Inventor
Sander Hougee
Adrianus Johannes Maria Vriesma
Johan Garssen
Jan Knol
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of BRPI0813391A2 publication Critical patent/BRPI0813391A2/pt
Publication of BRPI0813391B1 publication Critical patent/BRPI0813391B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/519—Breve
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Pulmonology (AREA)
  • Botany (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0813391A 2007-06-15 2008-06-13 composição para lactente e/ ou criança na primeira infância com oligossacarídeos não digeríveis e bifidobactéria não viável, e, usos da mesma BRPI0813391B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/NL2007/050290 WO2008153377A1 (en) 2007-06-15 2007-06-15 Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
PCT/NL2008/050376 WO2008153391A2 (en) 2007-06-15 2008-06-13 Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide

Publications (2)

Publication Number Publication Date
BRPI0813391A2 true BRPI0813391A2 (pt) 2014-12-30
BRPI0813391B1 BRPI0813391B1 (pt) 2018-12-11

Family

ID=39363590

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0813391A BRPI0813391B1 (pt) 2007-06-15 2008-06-13 composição para lactente e/ ou criança na primeira infância com oligossacarídeos não digeríveis e bifidobactéria não viável, e, usos da mesma

Country Status (18)

Country Link
US (2) US9456629B2 (pt)
EP (2) EP3491938A1 (pt)
CN (2) CN101801220A (pt)
AR (1) AR067020A1 (pt)
AU (1) AU2008262670B2 (pt)
BR (1) BRPI0813391B1 (pt)
CA (1) CA2691563C (pt)
CY (1) CY1121400T1 (pt)
ES (1) ES2706606T3 (pt)
HR (1) HRP20190180T1 (pt)
HU (1) HUE042392T2 (pt)
MY (1) MY162245A (pt)
NZ (1) NZ582264A (pt)
PL (1) PL2162020T3 (pt)
RU (1) RU2475051C2 (pt)
TR (1) TR201901325T4 (pt)
UA (1) UA100985C2 (pt)
WO (2) WO2008153377A1 (pt)

Families Citing this family (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080126195A1 (en) 2004-07-22 2008-05-29 Ritter Andrew J Methods and Compositions for Treating Lactose Intolerance
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
EP2356992B1 (en) * 2007-12-07 2017-08-16 N.V. Nutricia Bifidobactrium for dust mite allergy
PT2285387E (pt) * 2008-06-13 2016-02-09 Nutricia Nv Nutrição para a prevenção de infeções
EP2452574A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Age-tailored nutritional formula with particularly adapted caloric density for young infants
CA2746805A1 (en) * 2008-12-19 2010-06-24 Nestec S.A. Prevention and treatment of rotavirus diarrhoea
AU2010218439B2 (en) 2009-02-24 2016-10-20 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
WO2010105207A1 (en) † 2009-03-13 2010-09-16 The Regents Of The University Of California Prebiotic oligosaccharides
EP2251021B1 (en) * 2009-05-11 2012-02-22 Nestec S.A. Prevention and treatment of allergic diarrhoea
EP2251020A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
RU2556124C2 (ru) * 2009-05-11 2015-07-10 Нестек С.А. Lactobacillus johnsonii La1 NСС533 (CNCM 1-1225) И ИММУННЫЕ НАРУШЕНИЯ
EP2251022A1 (en) * 2009-05-11 2010-11-17 Nestec S.A. Non-replicating micro-organisms and their immune boosting effect
ITMI20091034A1 (it) * 2009-06-11 2010-12-12 Parmalat Spa Specie probiotica di bifidobacterium breve
EP2467032B1 (en) 2009-08-18 2018-02-21 Nestec S.A. A nutritional composition comprising bifidobacterium longum strains and reducing food allergy symptoms, especially in infants and children
ES2622091T5 (es) * 2009-08-18 2020-10-19 Cosucra Groupe Warcoing Sa Composiciones que contienen mezclas de fibras fermentables
EP2308498A1 (en) * 2009-09-30 2011-04-13 Nestec S.A. Administration of Bifidobacterium breve during infancy to prevent inflammation later in life
IT1398553B1 (it) * 2010-03-08 2013-03-01 Probiotical Spa Composizione comprendente batteri probiotici per il trattamento di patologie associate con le alterazioni del sistema immunitario.
EP3202406A1 (en) 2010-04-28 2017-08-09 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
WO2011149336A1 (en) * 2010-05-25 2011-12-01 N.V. Nutricia Immune imprinting nutritional composition
WO2011149335A1 (en) 2010-05-25 2011-12-01 N.V. Nutricia Immune imprinting nutritional composition
PL3097791T3 (pl) * 2010-06-04 2018-10-31 N.V. Nutricia Niestrawne oligosacharydy do doustnej indukcji tolerancji na białka pokarmowe
WO2011150949A1 (en) * 2010-06-04 2011-12-08 N.V. Nutricia Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins
EP2449890A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Powdered cereal compositions comprising non-replicating probiotic microorganisms
EP2455094A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect children against gastrointestinal infections
EP2452573A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Age-tailored nutritional composition with animal fats and vegetable fats
EP2454948A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
RU2600877C2 (ru) * 2010-12-06 2016-10-27 Н.В. Нютрисиа Ферментированное детское питание
SG191792A1 (en) 2010-12-31 2013-08-30 Abbott Lab Human milk oligosaccharides for modulating inflammation
PH12013501382A1 (en) 2010-12-31 2013-09-02 Abbott Lab0Ratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers or children using human milk oligosaccharides
CA2822500C (en) 2010-12-31 2022-07-26 Abbott Laboratories Human milk oligosaccharides to promote growth of beneficial bacteria
ES2708924T3 (es) 2010-12-31 2019-04-12 Abbott Lab Procedimientos de uso de oligosacáridos de la leche humana para mejorar la salud respiratoria de las vías respiratorias
MX338174B (es) 2010-12-31 2016-04-06 Abbott Lab Metodos para reducir la incidencia de la tension oxidativa al usar los oligosacaridos de leche humana, la vitamina c y los agentes antiinflamatorios.
SG191799A1 (en) 2010-12-31 2013-08-30 Abbott Lab Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated polyunsaturated fatty acids and uses thereof
CN107510040A (zh) 2010-12-31 2017-12-26 雅培制药有限公司 包含人乳低聚糖和核苷酸的营养型组合物以及其治疗和/或预防肠病毒感染的用途
IT1403661B1 (it) 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
CA2824960A1 (en) * 2011-02-04 2012-08-09 The Regents Of The University Of California Disialyllacto-n-tetraose (dslnt) or variants, isomers, analogs and derivatives thereof to prevent or inhibit bowel disease
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110793A1 (it) * 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
WO2012177556A2 (en) 2011-06-20 2012-12-27 H.J. Heinz Company Probiotic compositions and methods
WO2012177118A1 (en) 2011-06-22 2012-12-27 N.V. Nutricia Method for reducing the occurrence of infection in young children
CN103874427A (zh) * 2011-07-12 2014-06-18 雀巢产品技术援助有限公司 为了提高对在断奶期期间新引入食物的耐受性对健康年幼哺乳动物施用的益生菌剂
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
HK1199607A1 (en) 2011-08-29 2015-07-10 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
PL2768313T3 (pl) * 2011-10-18 2016-02-29 Nestec Sa Kompozycja do stosowania dla zwiększania absorpcji magnezu oraz/albo retencji magnezu w organizmie
US9662358B2 (en) * 2011-10-18 2017-05-30 Nestec S.A. Composition for use in the promotion of healthy bone growth and/or in the treatment of bone disease
WO2013062402A1 (en) * 2011-10-24 2013-05-02 N.V. Nutricia Allergy treatment with non- digestible oligosaccharide
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
US9974816B2 (en) * 2012-11-02 2018-05-22 N.V. Nutricia Synbiotics combination for brain improvement
RU2015125519A (ru) * 2012-11-29 2017-01-10 Нестек С.А. Cинбиотическая композиция и ее применение
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
RU2018129984A (ru) 2013-05-10 2019-03-15 Эйч. Джей. ХАЙНЦ КОМПАНИ БРЕНДС ЛЛСи Пробиотики и способы их применения
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
BR112016009357B1 (pt) * 2013-11-04 2021-09-14 N.V. Nutricia Usos de um ingrediente fermentado e oligossacarídeos não digeríveis na fabricação de uma fórmula para fórmula para recém-nascido ou de continuação para uso na redução da incidência de cólicas em um recém-nascido
MX2016006503A (es) * 2013-11-25 2016-08-05 Nestec Sa Formulacion de bifidobacterium lactis ncc 2818 tratada con calor que reduce las manifestaciones alergicas.
WO2016053085A1 (en) 2014-09-30 2016-04-07 N.V. Nutricia Composition comprising a uridine source and butyrate producing fibres for preventing gastrointestinal disorders
DK3209308T3 (da) * 2014-10-24 2022-10-03 Evolve Biosystems Inc Aktiverede bifidobakterier og fremgangsmåder til anvendelse deraf
US10609475B2 (en) 2014-12-05 2020-03-31 Stages Llc Active noise control and customized audio system
HUE035569T2 (en) 2014-12-23 2018-05-28 4D Pharma Res Ltd Bacteroides thetaiotaomicron strain and its use in reducing inflammation
KR20170091157A (ko) 2014-12-23 2017-08-08 4디 파마 리서치 리미티드 피린 폴리펩티드 및 면역 조정
PH12017550039B1 (en) 2015-03-05 2022-07-20 Socia‰Ta‰ Des Produits Nestla‰ S A Compositions for use in improving stool consistency or frequency in infants or young children
HUE045413T2 (hu) 2015-06-15 2019-12-30 4D Pharma Res Ltd Baktériumtörzseket tartalmazó készítmények
LT3360559T (lt) 2015-06-15 2019-12-27 4D Pharma Research Limited Kompozicijos, apimančios bakterijų kamienus
ES2753779T3 (es) 2015-06-15 2020-04-14 4D Pharma Res Ltd Blautia stercosis y wexlerae para la utilización en el tratamiento de enfermedades inflamatorias y autoinmunes
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
WO2017043962A1 (en) * 2015-09-11 2017-03-16 N.V. Nutricia Method for stimulating microbiota health after non-natural birth
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
CN108513545B (zh) 2015-11-20 2020-11-03 4D制药研究有限公司 包含细菌菌株的组合物
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
WO2017114901A1 (en) * 2015-12-29 2017-07-06 N.V. Nutricia Nutritional formula with non-digestible oligosaccharides and non-replicating lactic acid producing bacteria
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
SG11201807195VA (en) 2016-03-04 2018-09-27 4D Pharma Plc Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
MA45334A (fr) 2016-03-24 2019-01-30 Probiotical Spa Composition bactérienne d'acide lactique pour le traitement d'infections vaginales bactériennes par gardnerella vaginalis et, éventuellement, d'infections fongiques concurrentes
JP6853821B2 (ja) * 2016-05-31 2021-03-31 森永乳業株式会社 脳機能改善剤
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
HUE054164T2 (hu) 2017-05-22 2021-08-30 4D Pharma Res Ltd Baktériumtörzseket tartalmazó készítmények
JP6978514B2 (ja) 2017-05-24 2021-12-08 フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited 細菌株を含む組成物
ES2855701T3 (es) 2017-06-14 2021-09-24 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
JP2020523326A (ja) 2017-06-14 2020-08-06 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ 細菌株を含む組成物
SMT202000695T1 (it) 2017-06-14 2021-01-05 4D Pharma Res Limited Composizioni comprendenti ceppi batterici
CN110831608A (zh) * 2017-06-30 2020-02-21 N·V·努特里奇亚 预防疾病的合生素组合物
BR112019028006A2 (pt) * 2017-06-30 2020-07-07 N.V. Nutricia composição nutricional, uso de uma combinação de bifidobacterium breve e oligossacarídeos não digeríveis, e método para prevenir e/ou reduzir o risco de ocorrência de hipercolesterolemia e/ou aterosclerose
EP3769771A4 (en) * 2018-03-23 2021-11-03 Morinaga Milk Industry Co., Ltd. COMPOSITION TO PROMOTE SECRETION OF FGF21
TW202023590A (zh) * 2018-08-17 2020-07-01 英商4D製藥研究有限公司 包含細菌菌株之組合物
US20240307338A1 (en) * 2021-01-27 2024-09-19 Sichuan Jiuzhang Biological Science And Technology Co., Ltd. Use of pharmaceutical composition containing chlorogenic acid in preparation of medicament for treating pathologic jaundice
CN114767720A (zh) * 2022-05-12 2022-07-22 上海交通大学医学院附属瑞金医院 一种短双歧杆菌m-16v在制备药物中的应用
CN114949006A (zh) * 2022-06-10 2022-08-30 上海交通大学医学院附属瑞金医院 一种短双歧杆菌m-16v在制备缓解卵清蛋白诱导的食物过敏药物中的应用
EP4574160A1 (en) * 2023-12-20 2025-06-25 Hipp & Co Composition comprising bifidobacterium breve strain for use in the prevention of skin allergies

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2617758B2 (ja) * 1988-03-25 1997-06-04 株式会社ヤクルト本社 抗体産生増強型免疫賦活剤
US5602109A (en) * 1994-01-10 1997-02-11 Abbott Laboratories Method to enhance the immune system of a human
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
DE19836339B4 (de) * 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
US6077558A (en) * 1998-12-23 2000-06-20 Bristol-Myers Squibb Company Elemental nutritional products
CA2382670A1 (en) 1999-08-26 2001-03-01 Ganeden Biotech, Inc. Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications
FI109602B (fi) * 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
US20030157067A1 (en) * 2002-02-19 2003-08-21 Bartels Jennifer F. Formulation and method for preventing antibiotics-induced diaper rash
WO2004112509A2 (en) * 2003-06-23 2004-12-29 Nestec S.A. Nutritional formula for optimal gut barrier function
CA2543626C (en) * 2003-10-24 2013-08-27 N.V. Nutricia Synbiotic composition for infants
WO2005058335A1 (en) * 2003-12-17 2005-06-30 N.V. Nutricia Lactic acid producing bacteria and lung function
US8252769B2 (en) * 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
PT1629850E (pt) * 2004-08-24 2007-08-14 Nutricia Nv Composição nutricional que compreende a administração de oligossacarídeos indigeríveis
CN101128129A (zh) * 2005-02-28 2008-02-20 纽崔西亚公司 具有益生菌的营养组合物
CA2604338A1 (en) * 2005-04-13 2006-10-19 Nestec S.A. Infant formula with probiotics
AU2006240560B2 (en) 2005-04-27 2011-10-27 N.V. Nutricia Nutrition with lipids and non-digestible saccharides
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide

Also Published As

Publication number Publication date
PL2162020T3 (pl) 2019-04-30
US20100278781A1 (en) 2010-11-04
MY162245A (en) 2017-05-31
EP2162020A2 (en) 2010-03-17
EP3491938A1 (en) 2019-06-05
US20170049143A1 (en) 2017-02-23
RU2475051C2 (ru) 2013-02-20
AU2008262670A1 (en) 2008-12-18
NZ582264A (en) 2012-03-30
AR067020A1 (es) 2009-09-30
EP2162020B1 (en) 2018-10-31
HUE042392T2 (hu) 2019-06-28
WO2008153377A1 (en) 2008-12-18
CN105639631A (zh) 2016-06-08
AU2008262670B2 (en) 2014-02-13
WO2008153391A3 (en) 2009-02-05
TR201901325T4 (tr) 2019-02-21
BRPI0813391B1 (pt) 2018-12-11
CN101801220A (zh) 2010-08-11
US9456629B2 (en) 2016-10-04
CY1121400T1 (el) 2020-05-29
US9883692B2 (en) 2018-02-06
HRP20190180T1 (hr) 2019-03-22
WO2008153391A2 (en) 2008-12-18
RU2010101056A (ru) 2011-07-20
UA100985C2 (ru) 2013-02-25
CA2691563C (en) 2016-08-02
ES2706606T3 (es) 2019-03-29
CA2691563A1 (en) 2008-12-18

Similar Documents

Publication Publication Date Title
BRPI0813391A2 (pt) Nutrição pra lactente e criança na primeira infância, e, uso da mesma.
BRPI0813455A2 (pt) Derivado de 17beta-ciano-18a-homo-19-nor-androst-4-eno, seu uso e medicamentos contendo este derivado.
BRPI0821276A2 (pt) Produto, e, uso do produto
DE602006020813D1 (de) Kindersitz
EP1933936A4 (en) IMPREGNATED ENVELOPE OF MEDICAMENT
BRPI0718182A2 (pt) Oligorribonucleotídeos e seus usos.
BRPI0814267A2 (pt) Agentes citotóxicos compreendendo novos derivados de tomaicmicina e o seu uso terapêutico.
BRPI1008045A2 (pt) derivados de aminotetralina, composições farmacêuticas contendo-os, e seu uso em terapia
BRPI0718192A2 (pt) Corantes dispersos, sua preparação e seu uso.
BRPI0618200A2 (pt) dispositivo para movimentar criança
BRPI0719345A2 (pt) Di-hidroimidazóis substituídos e seu uso no tratamento de tumores.
BRPI0809829A2 (pt) Composição, artigo e embalagem
IT1394265B1 (it) Dispositivo di contenimento e/o di trasporto per bambini, particolarmente ma non esclusivamente, per passeggini, carrozzine, culle, seggiolini o simili
ES1061044Y (es) Asiento infantil para automoviles.
DE602006014125D1 (de) Banksitz mit beweglichen polstern
ATE481069T1 (de) Saugfähiger artikel mit wahrnehmungselement
ATE485023T1 (de) Saugfähiger einwegartikel mit entfaltbarem gurtband
BRPI0817044A2 (pt) Compostos de nicotinamida substituída e seu uso em medicamentos
BRPI0813937A2 (pt) Derivado de 17beta-ciano-19-nor-andros-4-eno, seu uso e medicamentos contendo o derivado
ES1062692Y (es) Dispositivo para la articulacion de asas en asientos infantiles, capazos-cuna y analogos
BRPI0812329A2 (pt) Umidificador para uso com produtos de tabaco, e, embalagem para produtos de tabaco
BRPI0812535A2 (pt) derivado de 17beta-ciano-19-androst-4-eno, seu uso e medicamentos compreendendo o derivado
EP1889613A4 (en) PHARMACEUTICAL COMPOSITION COMPRISING VITAMIN K
ITRM20050512A1 (it) Derivati 6-pirimidinici e pirimidinonici, e loro uso.
DE602006017569D1 (de) Pharmazeutische kombinationen mit lamivudin, stavudin und nevirapin

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A23L 33/00 (2016.01), A23L 29/30 (2016.01), A23L 3

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 11/12/2018, OBSERVADAS AS CONDICOES LEGAIS.